1. Proton pump inhibitors in the treatment of acid-dependent diseases;Dekhnich;Bull. Smolensk. State Med. Acad.,2011
2. The use of proton pump inhibitors for the treatment of acid-related diseases;Lazebnik;Arch. Intern. Med.,2013
3. (2017). Product Monograph Losec® (Omeprazole Delayed Release Capsules) 20 mg Omeprazole H+, K+-ATPase Inhibitor, AstraZeneca Canada Inc.
4. Junggren, U.K., and Sjöstrand, S.E. (1979). Substituted Pyridylsulfinylbenzimidazoles Having Gastric Acid Secretion Properties, Pharmaceutical Preparations Containing Same, and Intermediates for Their Preparation. (Patent No. EP0005129A1).
5. (2019, August 22). Trends in Drug Patenting—Case Studies: The Cases: 5. Omeprazole. apps.who.int. Available online: http://apps.who.int/medicinedocs/en/d/Js4915e/2.5.html.